Compound information
- Natural Products
- ZC1435749
- Molecular Formula
- C15H22NO7P
- Molecular Weight
- 359.113388674 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-(benzyloxycarbonylamino)-2-diethoxyphosphoryl-acetate
- InChI
- InChI=1S/C15H22NO7P/c1-4-22-24(19,23-5-2)13(14(17)20-3)16-15(18)21-11-12-9-7-6-8-10-12/h6-10,13H,4-5,11H2,1-3H3,(H,16,18)/t13-/m0/s1
- InChI Key
- KREPFQCNXAYHAW-ZDUSSCGKSA-N
- SMILES
- CCOP(=O)(OCC)[C@H](NC(=O)OCc1ccccc1)C(=O)OC
- Source
- ZINC000016698166
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 100.16 Å2 | LogP | 1.628 |
LogS | -2.422 | LogD | 1.341 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.43 | Pgp substrate | 0.004 |
HIA | 0.967 | F20 % | 0.992 |
F30 % | 0.906 | Caco-2 | -5.494 |
MDCK | -4.455 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.233 | PPB | 77.117 |
VD | 0.57 | Fu | 0.889 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.699 |
CYP2A6 substrate | 0.52 | CYP2B6 substrate | 0.687 |
CYP2C19 inhibitor | 0.904 | CYP2C19 substrate | 0.914 |
CYP2C8 substrate | 0.716 | CYP2C9 inhibitor | 0.023 |
CYP2C9 substrate | 0.998 | CYP2D6 inhibitor | 0.001 |
CYP2D6 substrate | 0.704 | CYP2E1 substrate | 0.503 |
CYP3A4 inhibitor | 0.019 | CYP3A4 substrate | 0.92 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.761 | CL | 4.236 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.121 | Hepatotoxicity | 0.904 |
Mutagenicity | 0.539 | Rat Oral Acute Toxicity | 0.042 |
FDAMDD | 0.111 | Skin Sensitization | 0.038 |
Carcinogenicity | 0.022 | Eye Corrosion | 0.008 |
Eye Irritation | 0.095 | Respiratory Toxicity | 0.049 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.732 | IGC50 | 2.393 |
LC50FM | 3.675 | LC50DM | 6.067 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.097 | NR-AR-LBD | 0.203 |
NR-AhR | 0.029 | NR-Aromatase | 0.056 |
NR-ER | 0.201 | NR-ER-LBD | 0.414 |
NR-PPAR-gamma | 0.176 | SR-ARE | 0.124 |
SR-ATAD5 | 0.315 | SR-HSE | 0.033 |
SR-MMP | 0.008 | SR-p53 | 0.013 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.